Recurrent and Relapsing Peritonitis: Causative Organisms and Response to Treatment

American Journal of Kidney Diseases

Volumn 54, Issue 4, 2009, Pages 702-710

  Szeto, Cheuk Chun ^a   Kwan, Bonnie Ching Ha ^a   Chow, Kai Ming ^a   Law, Man Ching ^a   Pang, Wing Fai ^a   Chung, Kwok Yi ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

antibiotics; nosocomial infection; Renal failure

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; GENTAMICIN; NETILMICIN; SULPERAZON; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CATHETER REMOVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DISEASE CONTROL; DISEASE COURSE; ENTEROCOCCUS; EXIT SITE INFECTION; FEMALE; GRAM NEGATIVE BACTERIUM; HEMODIALYSIS PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MICROORGANISM; MONOTHERAPY; MORTALITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONITIS; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CEFAZOLIN; CEFTAZIDIME; FEMALE; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETILMICIN; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN;

EID: 70349230856     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.04.032     Document Type: Article

References (25)

1. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 9 (1998) 1956-1964
2. Oreopoulos D.G., and Tzamaloukas A.H. Peritoneal dialysis in the next millennium. Adv Ren Replace Ther 7 (2000) 338-346
3. Szeto C.C., Wong T.Y., Leung C.B., et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58 (2000) 400-407
4. Szeto C.C., Chow K.M., Wong T.Y., et al. Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol 13 (2002) 1040-1045
5. Szeto C.C., Leung C.B., Chow K.M., et al. Change in bacterial aetiology of peritoneal-dialysis-related peritonitis over ten years: Experience from a center in South-East Asia. Clin Microbiol Infect 10 (2005) 837-839
6. Bloembergen W.E., and Port F.K. Epidemiological perspective on infections in dialysis patients. Adv Ren Replace Ther 3 (1996) 201-207
7. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 103 (2006) S55-S62
8. Fried L.F., Bernardini J., Johnston J.R., and Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 7 (1996) 2176-2182
9. Szeto C.C., Wong T.Y., Chow K.M., Leung C.B., and Li P.K. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study?. Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 18 (2003) 977-982
10. Piraino B., Bailie G.R., Bernardini J., et al., ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 Update. Perit Dial Int 25 (2005) 107-131
11. Bonadio T.L., and Diaz-Buxo J.A. Definition of recurrent peritonitis. Perit Dial Int 27 (2007) 716-719
12. Vas S.I. Peritonitis during CAPD. A mixed bag. Perit Dial Bull 1 (1981) 47-49
13. Keane W.F., Alexander S.R., Bailie G.R., et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 Update. Perit Dial Int 16 (1996) 557-573
14. Flanigan M.J., Hochstetler L.A., Langholdt D., and Lim V.S. Continuous ambulatory peritoneal dialysis catheter infections: Diagnosis and management. Perit Dial Int 14 (1994) 248-254
15. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing, 9th Informational Supplement. NCCLS document M100-S9 (1999), NCCLS, Villanova, PA
16. Szeto C.C., Chow V.C., Chow K.M., et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: A review of 210 consecutive cases. Kidney Int 69 (2006) 1245-1252
17. Szeto C.C., Chow K.M., Kwan B.C., et al. Staphylococcus aureus peritonitis complicating peritoneal dialysis: Review of 245 consecutive cases. Clin J Am Soc Nephrol 2 (2007) 245-251
18. Li P.K., Ip M., Law M.C., et al. Use of intra-peritoneal (IP) cefepime as monotherapy in the treatment of CAPD peritonitis. Perit Dial Int 20 (2000) 232-234
19. Leung C.B., Szeto C.C., Chow K.M., et al. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis-A randomized controlled trial. Perit Dial Int 24 (2004) 440-446
20. Szeto C.C., Chow K.M., Leung C.B., et al. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: A review of 104 cases. Kidney Int 59 (2001) 2309-2315
21. Berg R.D., Wommack E., and Deitch E.A. Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg 123 (1988) 1359-1364
22. Szeto C.C., Chow K.M., Chung K.Y., Kwan B.C., Leung C.B., and Li P.K. The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species. Nephrol Dial Transplant 20 (2005) 2793-2796
23. Szeto C.C., Kwan B.C., Chow K.M., et al. Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: Review of 232 consecutive cases. Clin J Am Soc Nephrol 3 (2008) 91-97
24. Zelenitsky S., Barns L., Findlay I., et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 36 (2000) 1009-1013
25. Pujol M., Peña C., Pallares R., Ayats J., Ariza J., and Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 13 (1994) 96-102